J. Cane (Oxford (Oxfordshire), United Kingdom), A. Gramegna (Milano (MI), Italy)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Correlation between initial oxygen desaturation and initial chest scan findings of COVID19
a. chaieb (Tunis, Tunisia), S. Maazaoui (Tunis, Tunisia), S. Habibech (Tunis, Tunisia), M. Friha (Tunis, Tunisia), T. Zneigui (Tunis, Tunisia), N. Mefteh (Tunis, Tunisia), S. Ghdira (Tunis, Tunisia), H. Racil (Tunis, Tunisia), N. Chaouch (Tunis, Tunisia)
|   |
Blood lactate level in patients with severe COVID-19: Does it have any added value?
R. Hassan (Telford, United Kingdom), H. Moudgil (Telford, United Kingdom), E. Crawford (Telford, United Kingdom), A. Makan (Telford, United Kingdom), S. Srinivasan (Telford, United Kingdom), N. Ahmad (Telford, United Kingdom)
| |
Predicting mortality in patients admitted to hospital with COVID-19 infection: a retrospective analysis of data for a District General Hospital in the United Kingdom
C. Davidson (Aylesbury, United Kingdom), H. Ellis (Aylesbury, United Kingdom), R. Arulanandam (Aylesbury, United Kingdom), D. Nair (Aylesbury, United Kingdom), H. Siddique (Aylesbury, United Kingdom), E. Tindall (Aylesbury, United Kingdom), E. Venizelou (Aylesbury, United Kingdom), A. Womersley (Aylesbury, United Kingdom), C. Campbell (Aylesbury, United Kingdom), M. Shahidi (Aylesbury, United Kingdom)
| |
Rapid SARS-CoV-2 antigen testing compared with RT-qPCR in patients suspected for COVID-19
G. Popova (Skopje, North Macedonia), K. Boskovska (Skopje, North Macedonia), I. Arnaudova Danevska (Skopje, North Macedonia)
| |
Severe COVID-19 patients : predictive factors for high oxygen requirement
S. Essebaa (Tunis, Tunisia), S. Daboussi (Tunis, Tunisia), S. Mhamdi (Tunis, Tunisia), N. Boubaker (Tunis, Tunisia), I. Mejri (Tunis, Tunisia), C. Aichaouia (Tunis, Tunisia), Z. Moatemri (Tunis, Tunisia), M. Khadhraoui (Tunis, Tunisia)
| |
Sarcopenia prevalence in recovered of COVID-19 patients.
M. Salgado Fernández (México City, Mexico), D. González Islas (México City, Mexico), A. Orea Tejeda (México City, Mexico), C. Sánchez Moreno (México City, Mexico), S. Hernández López (México City, Mexico), S. Galicia Amor (México City, Mexico), R. Hernández Zenteno (México City, Mexico), V. Peláez Hernández (México City, Mexico), O. Vázquez Díaz (México City, Mexico), J. Orozco Gutiérrez (México City, Mexico)
| |
CT quantification of lung lesions as a prognostic factor for severe lung damage in COVID-19 patients
B. Karaborni (La Marsa, Tunisia), H. Cherif (La Marsa, Tunisia), A. Boufaress (La Marsa, Tunisia), Z. Teyeb (La Marsa, Tunisia), S. Belakhel (La Marsa, Tunisia), M. Bougacha (La Marsa, Tunisia), M. Triki (La Marsa, Tunisia), F. Yangui (La Marsa, Tunisia), M. Charfi (La Marsa, Tunisia)
| |
COVID-19: the day after
E. Antonogiannaki (Athens, Greece), K. Thomas (Athens, Greece), D. Kavatha (Athens, Greece), E. Manali (Athens, Greece), D. Konstantonis (Athens, Greece), N. Arkoudis (Athens, Greece), A. Tsochatzis (Athens, Greece), P. Kazakou (Athens, Greece), S. Grigoropoulou (Athens, Greece), C. Psarrakis (Athens, Greece), M. Paneta (Athens, Greece), M. Kallieri (Athens, Greece), C. Oikonomopoulou (Athens, Greece), S. Loukidis (Athens, Greece), A. Antoniadou (Athens, Greece), S. Papiris (Athens, Greece)
| |
Mortality after hospitalisation for COVID19, and identification of prognostic factors on admission that increase mortality risk
K. Brooks (Durham, United Kingdom), S. Murphy (Durham, United Kingdom), M. Dickson (Durham, United Kingdom), L. Robinson (Durham, United Kingdom), N. Cummings (Durham, United Kingdom), F. Khalil (Durham, United Kingdom), M. Fayaz (Durham, United Kingdom)
| |
Differences between characteristics of patients admitted for Covid 19 between the first and second waves
A. Aguilar Galvez (MALAGA, Spain), E. Sanchez Alvarez (MALAGA, Spain), A. Martinez Mesa (MALAGA, Spain)
| |
Factors associated with admission of COVID-19 patients in intensive care unit
A. BAKEBE (Longjumeau, France), D. Cobarzan (Longjumeau, France), K. Chaouche (Longjumeau, France), G. Oliviero (Longjumeau, France), F. Durup (Longjumeau, France), S. Benhamida (Longjumeau, France), L. Decoux (Longjumeau, France)
| |
Psychiatric complications of COVID-19 pneumonia: preliminary results of a single-centre prospective study.
P. Potapov (Moscow, Russian Federation), A. Yakovleva (Moscow, Russian Federation), A. Volkov (Moscow, Russian Federation), M. Brovko (Moscow, Russian Federation), M. Kinkulkina (Moscow, Russian Federation), Y. Tikhonova (Moscow, Russian Federation), S. Moiseev (Moscow, Russian Federation)
| |
Pneumomediastinum in patients with Covid-19 pneumonia - case series
V. Nedelcu (Bucuresti, Romania), D. Gologanu (Bucuresti, Romania), V. Micu (Bucuresti, Romania), I. Ion (Bucuresti, Romania), L. Iliescu (Bucuresti, Romania), M. Balea (Bucuresti, Romania)
| |
The dual-use of nasal strip in the surveillance of active and convalescent SARS-CoV-2 cases
J. Tsun (Hong Kong, Hong Kong), S. Liu (Hong Kong, Hong Kong), G. Lui (Hong Kong, Hong Kong), K. Chan (Hong Kong, Hong Kong), K. Chan (Hong Kong, Hong Kong), R. Ng (Hong Kong, Hong Kong), P. Chan (Hong Kong, Hong Kong), A. Li (Hong Kong, Hong Kong), S. Lam (Hong Kong, Hong Kong), R. Chan (Hong Kong, Hong Kong)
| |
Residual symptoms in moderate to severe COVID-19 patients
S. ELFIDHA (TUNIS, Tunisia), S. Louhaichi (TUNIS, Tunisia), I. Khalfallah (TUNIS, Tunisia), S. Marzouki (TUNIS, Tunisia), L. Kaabi (TUNIS, Tunisia), R. Jebeli (TUNIS, Tunisia), M. Kharrat (TUNIS, Tunisia), J. Ammar (TUNIS, Tunisia), B. Hamdi (TUNIS, Tunisia), A. Hamzaoui (TUNIS, Tunisia)
| |
Minimizing aerosol leakage for nebulizer treatment in the COVID-19 pandemic
I. Lauwers (Eindhoven, Netherlands), M. Frankfort (Eindhoven, Netherlands), S. Dijkstra (Eindhoven, Netherlands), E. Pruijn (Eindhoven, Netherlands), L. Boormans (Eindhoven, Netherlands), R. Lauwers (Eindhoven, Netherlands), I. Lensen (Eindhoven, Netherlands), T. De Jong (Eindhoven, Netherlands), L. Verberne (Eindhoven, Netherlands), I. Idema (Nijmegen, Netherlands), N. Schouten (Eindhoven, Netherlands), C. Van Donkelaar (Eindhoven, Netherlands), H. Janssens (Rotterdam, Netherlands)
| |
An evaluation of neutrophils in COVID-19 patients
s. Ekstedt (Solna, Sweden), K. Piersiala (Solna, Sweden), Å. Kågedal (Solna, Sweden), M. Petro (Solna, Sweden), S. Kumlien Georén (Solna, Sweden), L. Cardell (Solna, Sweden)
| |
Are white blood cells count, neutrophil-to-lymphocyte ratio, lymphocyte to monocyte ratio and platelet-to-lymphocyte ratio associated with severe COVID-19 infection?
O. Asma (Sousse, Tunisia), B. Wafa (Sousse, Tunisia), H. Sabri (Sousse, Tunisia), G. Imen (Sousse, Tunisia), K. Asma (Sousse, Tunisia), A. Ahmed (Sousse, Tunisia), G. Abdelhamid (Sousse, Tunisia), H. Abdelaziz (Sousse, Tunisia), B. Mohamed (Sousse, Tunisia), A. Sana (Sousse, Tunisia)
| |
Prognostic value of neutrophil-to-lymphocyte ratio in hospitalized patients with COVID-19
N. Boubaker (Ariana, Tunisia), B. Hamdi (Ariana, Tunisia), S. Louhaichi (Ariana, Tunisia), I. Khalfallah (Ariana, Tunisia), M. Ferchichi (Ariana, Tunisia), S. Belkhir (Ariana, Tunisia), J. Ammar (Ariana, Tunisia), A. Hamzaoui (Ariana, Tunisia)
| |
Urinalysis parameters as a useful tool to predict severity in coronavirus disease 2019 (COVID19)
M. Mjid (TUNIS, Tunisia), W. JELASSI (TUNIS, Tunisia), Y. Yahia (TUNIS, Tunisia), Y. Messaoudi (TUNIS, Tunisia), S. Khiari (TUNIS, Tunisia), A. Allouche (TUNIS, Tunisia), M. Klila (TUNIS, Tunisia), Y. Ouahchi (TUNIS, Tunisia), M. Gharbi (TUNIS, Tunisia), S. Cheikhrouhou (TUNIS, Tunisia), H. Maghraoui (TUNIS, Tunisia), F. Daly (TUNIS, Tunisia), S. Merai (TUNIS, Tunisia), S. Toujani (TUNIS, Tunisia), B. Dhahri (TUNIS, Tunisia)
| |